MedPath

Effect of dexmedetomidine on proinflammatory markers.

Not Applicable
Conditions
Health Condition 1: - Health Condition 2: O- Medical and Surgical
Registration Number
CTRI/2022/08/044791
Lead Sponsor
Multidisciplinary Research Unit Guru Gobind Singh Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of American Society of Anesthesiologists (ASA) Physical Status I, II, III and (4) absence of clinical infections or positive urine culture will be included.

Exclusion Criteria

(1) pre-existing heart disorders, (2) long-term use of sedative drugs,steroid (3) fever within one�week (4) undergoing another surgery simultaneously (5) those who failed to be followed up will be excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the inflammatory cytokines markers, TNF and IL-6 after dexmedetomidine infusion in patients undergoing elective abdominal surgeries.Timepoint: at baseline (before surgery) and 24 hrs, 48 hrs & 72 hrs after surgery.
Secondary Outcome Measures
NameTimeMethod
To find incidence of postoperative systemic inflammatory response syndrome <br/ ><br>in patients.Timepoint: 24 hrs, 48 hrs and 72 hrs after surgery.
© Copyright 2025. All Rights Reserved by MedPath